OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
Xinle Cui, Clifford M. Snapper
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Xinle Cui, Clifford M. Snapper
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 125
Showing 1-25 of 125 citing articles:
Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
The development and improvement of immunodeficient mice and humanized immune system mouse models
Jiaxuan Chen, Shuzhen Liao, Zengzhi Xiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Jiaxuan Chen, Shuzhen Liao, Zengzhi Xiao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Burkitt lymphoma
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 80
Cristina López, Birgit Burkhardt, John K. C. Chan, et al.
Nature Reviews Disease Primers (2022) Vol. 8, Iss. 1
Closed Access | Times Cited: 80
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
Francesca Aloisi, Gavin Giovannoni, Marco Salvetti
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 338-349
Closed Access | Times Cited: 72
Francesca Aloisi, Gavin Giovannoni, Marco Salvetti
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 338-349
Closed Access | Times Cited: 72
mRNA vaccines: The future of prevention of viral infections?
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 49
Piotr Rzymski, Agnieszka Szuster−Ciesielska, Tomasz Dzieciątkowski, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 49
Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)
Huageng Huang, Yuyi Yao, Xinyi Deng, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 2
Open Access | Times Cited: 47
Huageng Huang, Yuyi Yao, Xinyi Deng, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 2
Open Access | Times Cited: 47
Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Epstein–Barr virus as a potentiator of autoimmune diseases
William H. Robinson, Shady Younis, Zelda Z. Love, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 729-740
Closed Access | Times Cited: 19
William H. Robinson, Shady Younis, Zelda Z. Love, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 11, pp. 729-740
Closed Access | Times Cited: 19
EBV-associated diseases: Current therapeutics and emerging technologies
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Srishti Chakravorty, Behdad Afzali, Majid Kazemian
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51
Luis Malpica, Mario L. Marques‐Piubelli, Brady Beltrán, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 7, pp. 951-965
Open Access | Times Cited: 41
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
Wenting Li, Xiaobing Duan, Xingxing Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 40
Wenting Li, Xiaobing Duan, Xingxing Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 40
EBV and Lymphomagenesis
Daniel Sausen, Ayeman Basith, Syed Muqeemuddin
Cancers (2023) Vol. 15, Iss. 7, pp. 2133-2133
Open Access | Times Cited: 26
Daniel Sausen, Ayeman Basith, Syed Muqeemuddin
Cancers (2023) Vol. 15, Iss. 7, pp. 2133-2133
Open Access | Times Cited: 26
Infectious Mononucleosis: An Updated Review
Alexander K. C. Leung, Joseph M. Lam, Benjamin Barankin
Current Pediatric Reviews (2023) Vol. 20, Iss. 3, pp. 305-322
Closed Access | Times Cited: 25
Alexander K. C. Leung, Joseph M. Lam, Benjamin Barankin
Current Pediatric Reviews (2023) Vol. 20, Iss. 3, pp. 305-322
Closed Access | Times Cited: 25
Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults
Jeremy D. Rubinstein, Keri Toner, Thomas G. Gross, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 1, pp. 101446-101446
Open Access | Times Cited: 18
Jeremy D. Rubinstein, Keri Toner, Thomas G. Gross, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 1, pp. 101446-101446
Open Access | Times Cited: 18
EBV-Upregulated B7-H3 Inhibits NK cell–Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression
Haiwen Chen, Xiaobing Duan, Xiaohong Deng, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 6, pp. 830-846
Open Access | Times Cited: 18
Haiwen Chen, Xiaobing Duan, Xiaohong Deng, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 6, pp. 830-846
Open Access | Times Cited: 18
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System
Oluf Andersen, Ingemar Ernberg, Anna Karin Hedström
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4599-4620
Open Access | Times Cited: 17
Oluf Andersen, Ingemar Ernberg, Anna Karin Hedström
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4599-4620
Open Access | Times Cited: 17
Treatment of Epstein-Barr Virus infection in immunocompromised patients
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 8
Martyna Pociupany, Robert Snoeck, Daan Dierickx, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116270-116270
Closed Access | Times Cited: 8
Virus‐induced host cell metabolic alteration
Syed Shahariar Bappy, Md. Muzammal Haque Asim, Mohammad Mainul Ahasan, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 7
Syed Shahariar Bappy, Md. Muzammal Haque Asim, Mohammad Mainul Ahasan, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 7
The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape
Mikhail Salnikov, Katelyn M. MacNeil, Joe S. Mymryk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Mikhail Salnikov, Katelyn M. MacNeil, Joe S. Mymryk
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
The role and impact of viruses on cancer development
Adolfo Contreras Rengifo, Sandra Amaya, Carolina Rodríguez‐Medina, et al.
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 170-184
Closed Access | Times Cited: 6
Adolfo Contreras Rengifo, Sandra Amaya, Carolina Rodríguez‐Medina, et al.
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 170-184
Closed Access | Times Cited: 6
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
Xueyi Zheng, Yuhua Huang, Kai Li, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1017-1017
Open Access | Times Cited: 27
Xueyi Zheng, Yuhua Huang, Kai Li, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1017-1017
Open Access | Times Cited: 27
Promising Role of Emodin as Therapeutics to Against Viral Infections
Qingqing Shao, Tong Liu, Wenjia Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Qingqing Shao, Tong Liu, Wenjia Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
mRNA‐based Vaccines Targeting the T‐cell Epitope‐rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti‐Tumor Immunity in Mice
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 16
Ge‐Xin Zhao, Guo‐Long Bu, Gang‐Feng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 16
Tumor vaccine based on extracellular vesicles derived from γδ‐T cells exerts dual antitumor activities
Xiwei Wang, Yanmei Zhang, Yuet Chung, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 9
Open Access | Times Cited: 14
Xiwei Wang, Yanmei Zhang, Yuet Chung, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 9
Open Access | Times Cited: 14
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective
Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Murali Muniraju, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Gabriela M. Escalante, Lorraine Z. Mutsvunguma, Murali Muniraju, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
